19269

    506197

    BLISSGVS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BLISS GVS PHARMA LTD Share Price Today

    BLISS GVS PHARMA LTD is currently trading at ₹504.95, down by ₹9.54 from the previous close. The stock touched an intraday high of ₹521.00 and a low of ₹500.00 during the latest trading session. Over the past one year, BLISS GVS PHARMA LTD has delivered a return of 233.54%, while the stock has gained 17.05% in the last one month.

    BLISS GVS PHARMA LTD performance

    Today’s low Today’s high
    ₹ 500.00 ₹ 521.00
    ₹ 504.95
    52 week low 52 week high
    ₹ 118.00 ₹ 553.00
    ₹ 504.95
    Open Price ₹ 514.50
    Prev. Close ₹ 514.50
    Volume (Shares) 210372.00
    Total traded value ₹ 1062.27
    Upper Circuit ₹ 540.20
    Lower Circuit ₹ 488.80
    info

    Investment Returns

    Over 1 Month 17.05% Over 3 Months 99.86% Over 6 Months 198.97% Over 1 Year 233.54%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BLISS GVS PHARMA LTD fundamentals


    • Market cap (Cr) 5,355.30
    • P/E Ratio (TTM) 56.26
    • Beta 1.30
    • Book Value / share 108.92
    • Return on equity 8.75%
    • EPS (TTM) 9.25
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 32.42
    info icon alternate text
    • Market cap (Cr) 5,446.50
    • P/E Ratio (TTM) 56.26
    • Beta 1.19
    • Book Value / share 108.92
    • Return on equity 8.75%
    • EPS (TTM) 9.25
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 32.42
    info icon alternate text

    BLISS GVS PHARMA LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 211.54
    Operating Expense 177.04
    Net Profit 32.42
    Net Profit Margin (%) 15.32
    Earnings Per Share (EPS) 3.06
    EBITDA 53.80
    Effective Tax Rate (%) 26.56
    Particulars DEC 2025 (Values in Cr)
    Revenue 164.68
    Operating Expense 147.10
    Net Profit 18.61
    Net Profit Margin (%) 11.30
    Earnings Per Share (EPS) 1.76
    EBITDA 34.57
    Effective Tax Rate (%) 26.41
    Particulars SEP 2025 (Values in Cr)
    Revenue 190.23
    Operating Expense 170.36
    Net Profit 24.79
    Net Profit Margin (%) 13.03
    Earnings Per Share (EPS) 2.35
    EBITDA 43.86
    Effective Tax Rate (%) 25.88
    Particulars JUN 2025 (Values in Cr)
    Revenue 163.36
    Operating Expense 143.39
    Net Profit 21.05
    Net Profit Margin (%) 12.88
    Earnings Per Share (EPS) 2.00
    EBITDA 43.35
    Effective Tax Rate (%) 31.11
    Particulars MAR 2025 (Values in Cr)
    Revenue 156.00
    Operating Expense 151.01
    Net Profit 11.45
    Net Profit Margin (%) 7.33
    Earnings Per Share (EPS) 1.08
    EBITDA 23.09
    Effective Tax Rate (%) 20.19
    Particulars MAR 2026 (Values in Cr)
    Revenue 729.81
    Operating Expense 637.90
    Net Profit 96.87
    Net Profit Margin (%) 13.27
    Earnings Per Share (EPS) 9.17
    EBITDA 175.59
    Effective Tax Rate (%) 27.41
    Particulars MAR 2025 (Values in Cr)
    Revenue 667.20
    Operating Expense 609.25
    Net Profit 68.97
    Net Profit Margin (%) 10.33
    Earnings Per Share (EPS) 6.56
    EBITDA 127.80
    Effective Tax Rate (%) 26.76
    Particulars MAR 2024 (Values in Cr)
    Revenue 605.46
    Operating Expense 527.61
    Net Profit 50.64
    Net Profit Margin (%) 8.36
    Earnings Per Share (EPS) 4.85
    EBITDA 99.59
    Effective Tax Rate (%) 27.91
    Particulars MAR 2023 (Values in Cr)
    Revenue 598.34
    Operating Expense 533.42
    Net Profit 85.48
    Net Profit Margin (%) 14.28
    Earnings Per Share (EPS) 8.23
    EBITDA 140.92
    Effective Tax Rate (%) 26.11
    Particulars MAR 2022 (Values in Cr)
    Revenue 636.36
    Operating Expense 545.33
    Net Profit 92.66
    Net Profit Margin (%) 14.56
    Earnings Per Share (EPS) 8.97
    EBITDA 144.57
    Effective Tax Rate (%) 26.69
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 112.76
    ROE % 12.01
    ROCE % 17.02
    Total Debt to Total Equity 0.05
    EBITDA Margin 25.36
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 99.68
    ROE % 8.95
    ROCE % 12.09
    Total Debt to Total Equity 0.09
    EBITDA Margin 20.15
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 92.38
    ROE % 11.02
    ROCE % 14.84
    Total Debt to Total Equity 0.11
    EBITDA Margin 23.25
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 84.87
    ROE % 9.01
    ROCE % 12.14
    Total Debt to Total Equity 0.12
    EBITDA Margin 17.98
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 78.97
    ROE % 5.35
    ROCE % 14.23
    Total Debt to Total Equity 0.14
    EBITDA Margin 20.04
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 109.20
    ROE % 8.75
    ROCE % 12.51
    Total Debt to Total Equity 0.04
    EBITDA Margin 24.06
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 100.47
    ROE % 6.74
    ROCE % 9.16
    Total Debt to Total Equity 0.07
    EBITDA Margin 19.15
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 94.41
    ROE % 7.91
    ROCE % 11.18
    Total Debt to Total Equity 0.08
    EBITDA Margin 23.18
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 89.96
    ROE % 9.56
    ROCE % 12.81
    Total Debt to Total Equity 0.10
    EBITDA Margin 23.55
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 82.12
    ROE % 11.53
    ROCE % 14.59
    Total Debt to Total Equity 0.11
    EBITDA Margin 22.72
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 213.30
    Total Assets 1300.83
    Total Liabilities 1300.83
    Total Equity 1091.84
    Share Outstanding 10
    Price to Book Ratio 1.17
    Return on Assets (%) 6.48
    Return on Capital (%) 7.25
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 215.61
    Total Assets 1211.58
    Total Liabilities 1211.58
    Total Equity 1002.98
    Share Outstanding 10
    Price to Book Ratio 1.19
    Return on Assets (%) 6.22
    Return on Capital (%) 6.92
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 102.98
    Total Assets 1156.85
    Total Liabilities 1156.85
    Total Equity 917.42
    Share Outstanding 10
    Price to Book Ratio 0.79
    Return on Assets (%) 6.12
    Return on Capital (%) 6.98
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 177.52
    Total Assets 1108.74
    Total Liabilities 1108.74
    Total Equity 846.46
    Share Outstanding 10
    Price to Book Ratio 0.94
    Return on Assets (%) 1.35
    Return on Capital (%) 1.58
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 144.55
    Total Assets 1076.78
    Total Liabilities 1076.78
    Total Equity 827.90
    Share Outstanding 10
    Price to Book Ratio 1.35
    Return on Assets (%) 6.36
    Return on Capital (%) 7.23
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 110.59
    Total Assets 1344.17
    Total Liabilities 1344.17
    Total Equity 1155.18
    Share Outstanding 10
    Price to Book Ratio 1.97
    Return on Assets (%) 7.20
    Return on Capital (%) 8.39
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 171.10
    Total Assets 1220.14
    Total Liabilities 1220.14
    Total Equity 1058.63
    Share Outstanding 10
    Price to Book Ratio 1.17
    Return on Assets (%) 5.65
    Return on Capital (%) 6.22
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 169.31
    Total Assets 1150.27
    Total Liabilities 1150.27
    Total Equity 988.44
    Share Outstanding 10
    Price to Book Ratio 1.19
    Return on Assets (%) 4.40
    Return on Capital (%) 4.8
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 84.60
    Total Assets 1139.69
    Total Liabilities 1139.69
    Total Equity 936.99
    Share Outstanding 10
    Price to Book Ratio 0.79
    Return on Assets (%) 7.50
    Return on Capital (%) 8.43
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 149.48
    Total Assets 1079.96
    Total Liabilities 1079.96
    Total Equity 851.43
    Share Outstanding 10
    Price to Book Ratio 0.94
    Return on Assets (%) 8.58
    Return on Capital (%) 9.89
    Particulars MAR 2026 (Values in Cr)
    Net Income 189.58
    Cash from Operations 181.01
    Cash from Investing -38.27
    Cash from Financing -89.21
    Net change in Cash 11.22
    Free Cash Flow 237.84
    Particulars MAR 2025 (Values in Cr)
    Net Income 125.63
    Cash from Operations 144.92
    Cash from Investing -75.58
    Cash from Financing -30.19
    Net change in Cash 0.12
    Free Cash Flow 221.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 146.06
    Cash from Operations 137.66
    Cash from Investing -83.18
    Cash from Financing -20.89
    Net change in Cash -1.26
    Free Cash Flow 165.99
    Particulars MAR 2023 (Values in Cr)
    Net Income 106.07
    Cash from Operations 78.86
    Cash from Investing -7.75
    Cash from Financing -24.93
    Net change in Cash 1.62
    Free Cash Flow 172.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 127.75
    Cash from Operations 169.42
    Cash from Investing -92.97
    Cash from Financing -23.73
    Net change in Cash 18.77
    Free Cash Flow 243.42
    Particulars MAR 2026 (Values in Cr)
    Net Income 133.46
    Cash from Operations 161.61
    Cash from Investing -51.39
    Cash from Financing -75.37
    Net change in Cash -3.61
    Free Cash Flow 221.16
    Particulars MAR 2025 (Values in Cr)
    Net Income 94.17
    Cash from Operations 127.53
    Cash from Investing -77.87
    Cash from Financing -26.55
    Net change in Cash -7.22
    Free Cash Flow 196.25
    Particulars MAR 2024 (Values in Cr)
    Net Income 111.34
    Cash from Operations 111.51
    Cash from Investing -65.83
    Cash from Financing -20.75
    Net change in Cash -4.42
    Free Cash Flow 150.18
    Particulars MAR 2023 (Values in Cr)
    Net Income 115.69
    Cash from Operations 81.52
    Cash from Investing -12.97
    Cash from Financing -26.04
    Net change in Cash 4.78
    Free Cash Flow 175.81
    Particulars MAR 2022 (Values in Cr)
    Net Income 123.65
    Cash from Operations 144.51
    Cash from Investing -92.28
    Cash from Financing -12.62
    Net change in Cash 9.14
    Free Cash Flow 218.18
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.34 13.00 1.51 240.17 23.12 38.85
    CIPLA LTD. 1437.95 30.52 3.37 116164.12 1165.55 1672.20
    FERMENTA BIOTECH LTD. 456.50 20.14 3.30 1343.52 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2485.65 43.76 18.57 42108.41 2088.00 3221.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.34 21.92 4.03 240.17 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.65 23.96 4.17 1545.71 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8237.40 107.58 23.59 20593.50 7630.00 9850.00
    ABBOTT INDIA LIMITED 27632.35 37.83 12.29 58718.74 25164.00 35280.00

    BLISS GVS PHARMA LTD shareholding pattern

    Holding
    49.15%
    35.35%
    10.44%
    5.04%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    BLISS GVS PHARMA LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    504.95 -1.85 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 518.30
    • 26 Days 483.00
    • 10 Days 514.50
    • 50 Days 430.20
    • 12 Days 511.80
    • 100 Days 356.00
    • 20 Days 496.50
    • 200 Days 283.00
    516.33 PIVOT
    First Support 505.17 First Resistance 525.67 Second Support 495.83 Second Resistance 536.83 Third Support 484.67 Third Resistance 546.17
    RSI 62.29 ADX 20.24 MACD 28.77 Williams % R -40.59 Commodity Channel Index (CCI) 41.85
    Date 2026-07-02 Week 480004.00 Same Day 211114.00 Month 528374.00
    1 Year 1.30 3 Year 1.14
    Over 1 Month
    17.05% down
    Over 1 Year
    233.54% down
    Over 3 Months
    99.86% down
    Over 3 Years
    72.37% down
    Over 6 Months
    198.97% down
    Over 5 Years
    35.56% down

    BLISS GVS PHARMA LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    08 Jul 2026 1.0 Final 08 Jul 2026 Equity shares
    18 Feb 2026 0.5 Interim 18 Feb 2026 Equity shares
    24 Jul 2025 0.5 Final 24 Jul 2025 Equity shares
    18 Jul 2024 0.5 Final 19 Jul 2024 Equity shares
    12 Jul 2023 0.5 Final 13 Jul 2023 Equity shares
    20 Jun 2022 0.5 Final 21 Jun 2022 Equity shares
    13 Sep 2021 0.5 Final 14 Sep 2021 Equity shares
    17 Sep 2020 0.5 Final 19 Sep 2020 Equity shares
    12 Sep 2019 1.0 Final 14 Sep 2019 Equity shares
    14 Aug 2018 1.0 Final 18 Aug 2018 Equity shares
    18 Sep 2017 0.6 Final 20 Sep 2017 Equity shares
    06 Sep 2016 0.5 Final 08 Sep 2016 Equity shares
    08 Sep 2015 0.5 Final 10 Sep 2015 Equity shares
    24 Feb 2015 0.2 Interim 25 Feb 2015 Equity shares
    13 Aug 2014 0.5 Final 18 Aug 2014 Equity shares
    01 Aug 2013 0.4 Final 05 Aug 2013 Equity shares
    25 Feb 2013 0.3 Interim 26 Feb 2013 Equity shares
    02 Aug 2012 0.4 Final 06 Aug 2012 Equity shares
    24 Nov 2011 0.35 Interim 25 Nov 2011 Equity shares
    14 Jul 2011 0.3 Final 18 Jul 2011 Equity shares
    25 Nov 2010 0.3 Interim 27 Nov 2010 Equity shares
    22 Jul 2010 0.5 Final 26 Jul 2010 Equity shares
    13 Aug 2009 0.15 Final 17 Aug 2009 Equity shares
    14 May 2008 0.1 Interim 15 May 2008 Equity shares
    13 Sep 2007 1.0 Final 17 Sep 2007 Equity shares
    Ex-Date Ex-Bonus Ratio
    30 Sep 2008 26 Sep 2008 3:5
    01 Oct 2005 28 Sep 2005 2:5
    Ex-Date Old FV NEW FV Record Date
    11 Mar 2008 10.0 1.0 18 Mar 2008
    Dividend date Dividend amount Dividend type Record date Instrument type
    08 Jul 2026 1.0 Final 08 Jul 2026 Equity shares
    18 Feb 2026 0.5 Interim 18 Feb 2026 Equity shares
    24 Jul 2025 0.5 Final 24 Jul 2025 Equity shares
    18 Jul 2024 0.5 Final 19 Jul 2024 Equity shares
    12 Jul 2023 0.5 Final 13 Jul 2023 Equity shares
    20 Jun 2022 0.5 Final 21 Jun 2022 Equity shares
    13 Sep 2021 0.5 Final 14 Sep 2021 Equity shares
    17 Sep 2020 0.5 Final 19 Sep 2020 Equity shares
    12 Sep 2019 1.0 Final 14 Sep 2019 Equity shares
    14 Aug 2018 1.0 Final 18 Aug 2018 Equity shares
    18 Sep 2017 0.6 Final 20 Sep 2017 Equity shares
    06 Sep 2016 0.5 Final 08 Sep 2016 Equity shares
    08 Sep 2015 0.5 Final 10 Sep 2015 Equity shares
    24 Feb 2015 0.2 Interim 25 Feb 2015 Equity shares
    13 Aug 2014 0.5 Final 18 Aug 2014 Equity shares
    01 Aug 2013 0.4 Final 05 Aug 2013 Equity shares
    25 Feb 2013 0.3 Interim 26 Feb 2013 Equity shares
    02 Aug 2012 0.4 Final 06 Aug 2012 Equity shares
    24 Nov 2011 0.35 Interim 25 Nov 2011 Equity shares
    14 Jul 2011 0.3 Final 18 Jul 2011 Equity shares
    25 Nov 2010 0.3 Interim 27 Nov 2010 Equity shares
    22 Jul 2010 0.5 Final 26 Jul 2010 Equity shares
    13 Aug 2009 0.15 Final 17 Aug 2009 Equity shares
    14 May 2008 0.1 Interim 15 May 2008 Equity shares
    13 Sep 2007 1.0 Final 17 Sep 2007 Equity shares
    Ex-Date Ex-Bonus Ratio
    30 Sep 2008 26 Sep 2008 3:5
    01 Oct 2005 28 Sep 2005 2:5
    Ex-Date Old FV NEW FV Record Date
    11 Mar 2008 10.0 1.0 18 Mar 2008

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Bliss GVS Pharma Ltd?

    Answer Field

    Bliss GVS Pharma Ltd share price is for NSE ₹ 504.95 & for BSE ₹ 513.55 as on Jul 16 2026 03:30 PM.

    What is the Market Cap of Bliss GVS Pharma Ltd Share?

    Answer Field

    The market cap of Bliss GVS Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 16 2026 03:30 PM.

    What is the 52 Week High and Low of Bliss GVS Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Bliss GVS Pharma Ltd for NSE is ₹ 553.00 and ₹ 118.00 and for BSE is ₹ 552.90 and ₹ 118.35.

    What is 1 year return for Bliss GVS Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been 233.54%.

    What is the P/E Ratio of Bliss GVS Pharma Ltd Share?

    Answer Field

    As on Jul 16 2026 03:30 PM the price-to-earnings (PE) ratio for Bliss GVS Pharma Ltd share is 56.26.

    What is the PB ratio of Bliss GVS Pharma Ltd Share?

    Answer Field

    As on Jul 16 2026 03:30 PM, the price-to-book (PB) ratio for Bliss GVS Pharma Ltd share is 108.92.

    How to Buy Bliss GVS Pharma Ltd Share?

    Answer Field

    You can trade in Bliss GVS Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Bliss GVS Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Bliss GVS Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Bliss GVS Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |